Get the Stockscreener App
2.285
18.68%
-0.525
After Hours:
2.31
0.025
+1.09%
Xortx Therapeutics Inc stock is traded at $2.285, with a volume of 61,486.
It is down -18.68% in the last 24 hours and down -0.63% over the past month.
XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.
See More
Previous Close:
$2.81
Open:
$2.78
24h Volume:
61,486
Relative Volume:
2.62
Market Cap:
$3.18M
Revenue:
-
Net Income/Loss:
$-2.66M
P/E Ratio:
-3.8077
EPS:
-0.6001
Net Cash Flow:
$-2.83M
1W Performance:
+6.40%
1M Performance:
-0.63%
6M Performance:
-49.58%
1Y Performance:
-46.92%
1-Day Range:
$2.25
$2.78
1-Week Range:
$1.94
$3.00
52-Week Range:
$1.725
$7.05
Xortx Therapeutics Inc Stock (XRTX) Company Profile
Compare XRTX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XRTX
Xortx Therapeutics Inc
|
2.285 | 3.91M | 0 | -2.66M | -2.83M | -0.6001 |
VRTX
Vertex Pharmaceuticals Inc
|
446.78 | 112.92B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
767.85 | 81.99B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
800.50 | 48.82B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.28 | 43.66B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.42 | 34.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Xortx Therapeutics Inc Stock (XRTX) Latest News
Aug Update: Can XORTX Therapeutics Inc continue delivering strong returnsWeekly Trade Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Bond Watch: Is XORTX Therapeutics Inc a speculative investmentWall Street Watch & Low Risk Entry Point Tips - baoquankhu1.vn
Long term debt to total equity ratio of XORTX Therapeutics, Inc. – TRADEGATE:ANU - TradingView
XORTX Therapeutics, Inc. Revenue Breakdown – LS:A427MJ - TradingView
Tangible book value per share of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
XORTX Therapeutics, Inc. Balance Sheet – LS:A427MJ - TradingView
XORTX Therapeutics, Inc. Dividends – LS:A427MJ - TradingView
Operating margin % of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Discontinued operations of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
EBITDA margin % of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Gross profit of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Cash from investing activities of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
XORTX Therapeutics, Inc. Cash Flow – LSX:A427MJ - TradingView
XORTX Therapeutics, Inc. Cash Flow – LS:A427MJ - TradingView
Net income before discontinued operations of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Diluted earnings per share (diluted EPS) of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Non-operating income (total) of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
EBIT per share of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
EBITDA margin % of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Net margin % of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Enterprise value to EBITDA ratio of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Net current asset value per share of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Operating margin % of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Non-controlling/minority interest of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Price to cash flow ratio of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Price to cash flow ratio of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
CapEx per share of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Long term debt to total equity ratio of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Total common shares outstanding of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
XORTX Therapeutics, Inc. Statistics – LS:A427MJ - TradingView
Total revenue of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Equity in earnings of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Diluted shares outstanding of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Non-operating income (total) of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
XORTX Therapeutics, Inc. Balance Sheet – LSX:A427MJ - TradingView
Debt to equity ratio of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Diluted earnings per share (diluted EPS) of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Gross margin % of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Net current asset value per share of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Non-controlling/minority interest of XORTX Therapeutics, Inc. – LS:A427MJ - TradingView
Enterprise value of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Net margin % of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Current ratio of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Net income before discontinued operations of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Operating cash flow per share of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
XORTX Therapeutics, Inc. Financial Statements – LS:A427MJ - TradingView
EBITDA per share of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
XORTX Therapeutics, Inc. Earnings and Revenue – LSX:A427MJ - TradingView
XORTX Therapeutics, Inc. Earnings and Revenue – LS:A427MJ - TradingView
Price to book ratio of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
CapEx per share of XORTX Therapeutics, Inc. – LSX:A427MJ - TradingView
Xortx Therapeutics Inc Stock (XRTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.57%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):